Literature DB >> 17532599

Urinary detection of podocyte injury.

Marcello Camici1.   

Abstract

Glomerular epithelial cell (podocyte) biology has been focused on in the last few years. The emerging understanding in podocyte biology has improved the molecular mechanism knowledge in many glomerular diseases. Urinary podocyte count and measurement of urinary podocyte specific markers (nephrin and podocalyxin) have been developed to detect podocyte injury. We discuss the emerging clinical importance of the urinary podocyte count in experimental and human glomerular disease, as well as measurement of urinary podocyte specific marker.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17532599     DOI： 10.1016/j.biopha.2006.12.009

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN： 0753-3322            Impact factor:   6.529


  15 in total

1.  Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.

Authors:  Akihiro Fukuda; Larysa T Wickman; Madhusudan P Venkatareddy; Yuji Sato; Mahboob A Chowdhury; Su Q Wang; Kerby A Shedden; Robert C Dysko; Jocelyn E Wiggins; Roger C Wiggins
Journal:  Kidney Int       Date:  2011-09-21       Impact factor: 10.612

2.  Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases.

Authors:  Larysa Wickman; Farsad Afshinnia; Su Q Wang; Yan Yang; Fei Wang; Mahboob Chowdhury; Delia Graham; Jennifer Hawkins; Ryuzoh Nishizono; Marie Tanzer; Jocelyn Wiggins; Guillermo A Escobar; Bradley Rovin; Peter Song; Debbie Gipson; David Kershaw; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 10.121

3.  Evaluation of the urinary podocalyxin and nephrin excretion levels to determine a safe time interval between two sessions of SWL for renal stones: a non randomized exploratory study.

Authors:  Hüseyin Kocatürk; Nursen Atasoy; Fevzi Bedir; İbrahim Karabulut; Engin Şebin; Kemal Sarica
Journal:  Int Urol Nephrol       Date:  2019-07-18       Impact factor: 2.370

4.  Urinary podocalyxin as a possible novel marker of intrauterine nephrogenesis and extrauterine podocyte injury.

Authors:  Taihei Hayashi; Shuko Tokuriki; Takashi Okuno; Genrei Ohta; Aiko Igarashi; Yusei Ohshima
Journal:  Pediatr Nephrol       Date:  2017-04-25       Impact factor: 3.714

Review 5.  Therapeutic targets in focal and segmental glomerulosclerosis.

Authors:  Peter J Lavin; Rasheed Gbadegesin; Tirupapuliyur V Damodaran; Michelle P Winn
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-07       Impact factor: 2.894

6.  Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker.

Authors:  Akihiro Fukuda; Larysa T Wickman; Madhusudan P Venkatareddy; Su Q Wang; Mahboob A Chowdhury; Jocelyn E Wiggins; Kerby A Shedden; Roger C Wiggins
Journal:  Nephrol Dial Transplant       Date:  2012-08-03       Impact factor: 5.992

7.  Detection of urinary podocytes and nephrin as markers for children with glomerular diseases.

Authors:  Pei Wang; Min Li; Qicai Liu; Bo Chen; Zequan Ji
Journal:  Exp Biol Med (Maywood)       Date:  2014-09-21

8.  ELISA analysis of urinary nephrin and podocalyxin standardized by aquaporin-2 in adult patients with nephrotic syndrome.

Authors:  Bin Zhu; Xian-fa Li; Xiao-ling Zhu; Yi Lin; Sen Zhong; Cai-feng Zhu; Xuan-li Tang; Yun-qing Hu; Xiao-xia Cheng; Yong-jun Wang
Journal:  J Nephrol       Date:  2014-04-16       Impact factor: 3.902

Review 9.  Podocyte dysfunction in aging--related glomerulosclerosis.

Authors:  Marcello Camici; Angelo Carpi; Giuseppe Cini; Fabio Galetta; Nader Abraham
Journal:  Front Biosci (Schol Ed)       Date:  2011-06-01

10.  ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases.

Authors:  Paul Gutwein; Anja Schramme; Mohamed Sadek Abdel-Bakky; Kai Doberstein; Ingeborg A Hauser; Andreas Ludwig; Peter Altevogt; Stefan Gauer; Anja Hillmann; Thomas Weide; Christine Jespersen; Wolfgang Eberhardt; Josef Pfeilschifter
Journal:  J Biomed Sci       Date:  2010-01-13       Impact factor: 8.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.